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The aim of the study was to formulate metronidazole tablets using starch from Xanthosoma 
sagittifolium as binder and disintegrant in metronidazole tablets. Metronidazole tablets were produced 
by wet granulation method using X. sagittifolium starch as binder at concentrations of 5, 10, 15 and 20% 
w/w, and as disintegrant (5% w/w). The micromeritic properties of the granules were determined using 
the direct and indirect methods. The necessary official and non official tests were performed on the 
tablets to include uniformity of tablets weight, content of active ingredient, disintegration test, 
hardness, friability tests and in vitro drug release. Also, the phytochemical constituents of the starch 
were determined. The results show that the granules had a good flow and values obtained were within 
the specified limits for the production of good quality tablets. Deviations obtained from the tablet 
weight uniformity test were significantly (p< 0.05) below 5%. Tablets disintegration time ranged from 
3.00 ± 0.08 min to 14.00 ± 0.10 min for M1 and M4 tablets formulated with 5 and 20% of X. sagittifolium 
starch respectively. The tablets hardness ranged from 7.20 ± 1.25 to 8.55 ± 1.17 kgf. In vitro release 
showed that M1 tablets had T25, T50 and T90 % at 5, 13 and 23 min respectively, while M4 tablets had T25, 
T50 and T90 % at 8, 18 min and were unable to release 90% of metronidazole at 30 min. Phytochemical 
analysis showed that the starch contained alkaloids, glycosides, carbohydrate and steroids. Therefore, 
starch from X. sagittifolium could be used to formulate metronidazole tablets for improved oral 
bioavailability of metronidazole. 
 





In recent years, pharmaceutical scientists have been 
paying increasing attention to the extraction, develop-
ment and use of starches in the formulation of dosage 
forms (Singh and Nath, 2012; Ogaji, 2011;  Builders et 
al., 2011;  Narkhede et al 2011;  Peerapattana et al., 
2010; Gangwarm  et al, 2010). Natural polymers have 
advantages over the synthetic and semi-synthetic poly-
mers which include better biocompatibility, relatively 
cheap, non toxic, less expensive, easily accessible and 
physiologically inert. The danger of use of synthetic 
polymer matrix materials which often goes along with 
detrimental effects on incorporated drug during manufac-
turing of formulations or after application are completely 
avoided (Reithmeier et al., 2001). 
Starch is a multipurpose excipient in tablet formulation, 
and it is used as a binder, disintegrant and filler (Adebayo 
and Itiola, 2003). Disintegrants are essential components 
in tablet formulations. Disintegrants may exert its action 
by swelling, wicking or deformation (Isah et al., 2009). 
Starch is the commonest disintegrant in tablet formulation 
 









and is believed to act by swelling (Rubinstein, 1988), 
however, current research has shown that most starches 
exert their disintegrant actions by deformation (Ofoefule, 
2002). Starch grains are generally elastic and at certain 
compression pressure, starch may undergo permanent 
deformation. These permanently deformed grains are rich 
in energy and when exposed to water, the energy is 
released causing disintegration of tablets (Ofoefule, 
2002). Starches are widely available and have been very 
useful in tablet production due to their inertness, cheap-
ness and utilization as fillers, binders, disintegrants and 
glidants and a lot of effort has been expended on the 
development of new starches from local sources as 
pharmaceutical excipients (Esezobo and Ambujam, 1982; 
Weirik et al., 1996; Alebiowu and Itiola, 2001; Olayemi et 
al., 2008).  
Binders are polymeric materials which possess both 
cohesive and adhesive properties (Ofoefule, 2002; 
Momoh et al., 2012). Binding agents are incorporated into 
tablets during granulation in order to improve formation of 
agglomerates and the flowability of the drug and to 
enhance compressibility. These agents coat the drug 
particles and therefore the rate of solution of the binder in 
water can determine the release rate of drug from the 
tablet (Momoh et al., 2012). Excessive binder concen-
tration yield slow disintegrating and hard tablets while 
insufficient binder concentration gives poor adhesive, soft 
tablets which tend to cap (Momoh et al., 2012). Binders 
confer structural strength required by tablets during pro-
cessing, handling, packaging and transportation (Emeje 
et al., 2008). Binders ameliorate capping and lamination 
by decreasing the plastoelasticity of pharmaceutical 
powders. Materials used as binders predominantly 
display plastic compaction characteristics. Hence, when 
incorporated into elastic or fragmenting natured powders, 
they impart plasticity to them, thereby reducing their 
plastoelasticity (Uhumwangho and Okor, 2004). 
Metronidazole is a poorly compressible antiprotozoal 
and anti parasitic agent that is very effective in the 
treatment of amoebiasis, trichomoniasis, giardiasis and 
many other parasitic diseases (Chukwu and Udeala, 
2005; Phillips and Samuel, 2006).  It also has poor water 
solubility (Obitte et al., 2008). Cocoyam starch, in a 
previous research work was found to possess superior 
moisture sorption capacities when it was compared with 
corn starch BP (Adebayo and Itiola, 1998). Natural, 
synthetic and semi-synthetic binders and disintegrants 
including mucilages, gums or starch from cashew, 
plantain, maize, okra, Irvinga gabonensis in addition to 
gelatin and acacia have been applied in the formulation 
of metronidazole tablets (Abdulsamad et al., 2008; Odeku 
and Patani, 2005; Chukwu and Udeala 2005; Momoh et 
al., 2009; Itiola and Pipel, 1986 and Shittu et al., 2010).  
The economic importance of starch from cocoyam 
(Xanthosoma sagittifolium) stem ranges from both its 
high yield of starch as well as the functionality of starches 
derived from them. The granules are highly digestible and 




their sizes are in a range lower than 5 µm (Car et al., 
1995; Aboubakar et al., 2008). Several reports has 
shown that cocoyam starch exhibit visco-elastic proper-
ties characterized by force of adhesion and relaxation, 
ability to absorb water and swell etc (Njintang et al., 
2007; Rodriguez-Miranda et al., 2011; Ahromrit and 
Nema, 2010; Ammar et al., 2009). This makes X. 
sagittifolium starch a candidate material for use in the 
formulation of poorly compressible metronidazole powder. 
The aim of the study therefore, was to evaluate the 
binder and exo-disintegrant properties of starch from X. 
sagittifolium in metronidazole tablet. 
 
 
MATERIALS AND METHODS  
 
Metronidazole was from Evans Pharmaceutical Ltd., England, 
lactose was from Merck, Germany, (BDH, England), and magne-
sium stearate was from May and Baker, England. Starch was 
extracted from the tubers of X. sagittifolium purchased from the 
market of Nsukka, Nigeria. All other reagents and solvents were of 
analytical grade and were used as supplied.  
 
 
Extraction and purification of X.  sagittifolium  
 
X. sagittifolium was purchased from Orba market in Nsukka in 
Enugu state, Nigeria in February, 2011. The tubers were cleaned 
by removing the soil and washed with water. The bark were 
properly peeled and rewashed with clean water containing 1% 
sodium metabisulphite. After washing, the X. sagittifolium tubers 
were reduced to a fine pulp in a hammer mill. The pulp was 
separated from the rasped X. sagittifolium by means of a muslin 
cloth and agitation was provided using hands. During screening, the 
water used contained 1% sodium metabisulphite in order to avoid 
discolouration of the starch by oxidative enzymes. The obtained 
starch suspension was allowed to settle under gravity and the 
supernatant was decanted. The starch suspension was washed 
severally using three times its volume of water for three days with 
intermittent shaking and changing of water (Ajali, 2004). Dewatering 
was done using a bag with pores of about 100 mm and pressure 
was applied using hand. The starch was dried in a tray dryer 
(Manesty Ltd, Liverpool, England) at 40°C. The dried starch was 





Phytochemical tests were carried out on the starch for the presence 
of alkaloids, steroids, glycosides, carbohydrates. The tests were 
carried out using standard procedures of analysis (Harborne, 1993; 
Sofowora, 1993; Trease and Evans, 2002). 
 
 
Preparation of granules 
 
Granules were prepared by wet granulation method using X. 
sagittifolium starch as the binder at concentrations of 5, 10, 15 and 
20% (w/w). Details of granulation are given in Table 1. Lactose was 
used as the diluents and 5% (w/w) X. sagittifolium starch, added 
extra granularly, served as the disintegrant. The powder samples 
were dried and mixed for 10 min in a tumbler mixer. The mixtures 
were moistened with the appropriate amount of binder solution 
prepared in distilled water. The homogeneous wet mass was then 













M1 M2 M3 M4 
Metronidazole 200.0 200.0 200.0 200.0 
X. sagittifolium starch (paste) 15.0 30.0 45.0 60.0 
X. sagittifolium starch 15.0 15.0 15.0 15.0 
Magnesium stearate 3.0 3.0 3.0 3.0 
Lactose   300.0 300.0 300.0 300.0 
 
M1, M2, M3 and M4 are various batches of metronidazole tablets containing 5, 10, 15 and 20 % Xanthosoma 




hot air oven at 60°C for 1 h. Thereafter, the dried granules were 
screened through a 1.0 mm sieve.  
 
 
Characterisation of granules 
 
Bulk and tapped densities 
 
A 50 g quantity of the granules was placed in a 100 ml measuring 
cylinder and the volume occupied by the granules was recorded as 
the bulk volume. The bulk density was obtained using Equation 1: 
 
Bulk density =                            (1) 
 
The cylinder was tapped on a wooden platform by dropping the 
cylinder from a height of one inch at 2 s interval until there was no 
significant change in volume reduction. The volume occupied by the 
sample was then recorded as the tapped volume. The tapped 
density was calculated using the formula: 
 
Tapped density = 
)(  volumeTapped
(M) sampleofMass




Flow rate and angle of repose 
 
A funnel was properly clamped onto a retort stand. A funnel of 
known efflux tube length, orifice and base diameter was used for 
the study. A 50 g quantity of the granules was weighed out and 
gradually transferred into the funnel with the funnel orifice closed 
with a shutter. The time taken for the entire granules to flow through 
the orifice was recorded. The flow rate was obtained by dividing the 
mass of the sample by the time of flow in seconds (Aulton, 2007; 
Chime et al., 2012).  
The dynamic angle of repose was determined by measuring the 
height of heap of powder formed using a cathetometer; the radius 
was obtained by dividing the diameter by two. Angle of repose (Ɵ) 
for each granule was calculated using Equation 3: 
 
 Ɵ = tan
-1
                                                                                      (3) 
 
 
Compressibility index and Hausner’s quotient 
 
Carr’s compressibility indices (%) of the granules were obtained 
using the formula: 
Carr’s Index (%) =  Tapped density- Bulk density  ×100 
                                   Tapped density        (4) 
 
Hausner’s quotient (HQ) was obtained using the formula: 
 
HQ=                                                                     (5) 
 
 
Preparation of tablets 
 
The granules were treated with magnesium stearate and then 
compressed at 46 to 48 kgf using a 9.0 mm punch and die set fitted 
into an automated F3 Manesty Single Punch tabletting machine. 
 
 
Evaluation of tablets 
 
Disintegration time test 
 
The disintegration time test was performed using an Erweka ZT 120 
basket and rack assembly and 0.I N Hydrochloric acid maintained 
at 37.0 ± 1.0°C as the disintegration medium. Ten (10) tablets from 
each batch were used for the test and the procedure being as 
stipulated in the BP (2009). 
 
 
Uniformity of weight  
 
Twenty (20) tablets were randomly selected from each batch of the 
metronidazole tablets. The tablets were weighed twice, individually, 
using an electronic balance (Ohaus Adventurer, China) and the 
mean individual weights recorded. The mean weight, standard 
deviation and percentage deviation were calculated (BP, 2009).  
 
 
Tablet friability test 
 
Twenty (20) tablets randomly selected from each batch of the 
tablets were used for this study. The tablets were dedusted and 
weighed. The tablets were placed into the drum of the friabilator 
(Erweka GmbH, Germany) and rotated at 25 rpm for 4 min. The 
tablets were removed from the friabilator, dedusted and reweighed. 
























Table 2.  Micromeritic properties of metronidazole granules. 
  
Batch ℓB (g/ml ± SD)* ℓT (g/ml ± SD)* A.R (
o 
± SD)* C.I (%) HQ Flow rate (g/sec ± SD)* 
M1 0.50  0.07 0.64  0.05 24.94  0.23 21.88 1.28 13.73  0.27 
M2 0.51  0.03 0.62  0.12 18.43  0.11 18.51 1.23 13.68  0.10 
M3 0.56  0.10 0.71  0.04 17.43  0.10 21.74 1.28 12.79  0.11 
M4 0.57  0.07 0.71  0.05 25.77  0.10 19.14 1.24 13.51  0.17 
 
Values shown are mean ± SD (*n = 3). M1, M2, M3 and M4, metronidazole granules prepared with 5, 10, 15 and 20% Xanthosoma sagittifolium 









Hardness/crushing strength test 
 
This test was carried out using Monsanto-Stokes hardness tester 
(Manesty, England). Ten (10) tablets from each batch were 
randomly selected. Each tablet was placed between the jaws of the 
hardness tester and force was applied by adjusting the knob of 




Content of active ingredient  
 
Beer’s calibration curve for metronidazole was obtained at a con-
centration range of 0.1 to 0.9 mg% in 0.1 N HCl at a predetermined 
wavelength of 277 nm. Twenty (20) tablets were randomly selected 
from each batch of the tablets. The tablets were weighed together 
and crushed in a mortar with a pestle. An amount equivalent to the 
average weight of the crushed tablet was weighed out, dispersed in 
the medium and filtered with a non adsorbent filter paper (Whatman 
No. 1). An aliquot of the filtrate was assayed using spectrophoto-
meter (Jenway 6305, UK). The absorbance readings were recorded 
and the concentration of metronidazole in each tablet was 
calculated with reference to Beer’s plot.   
 
 
In vitro release studies  
 
The in vitro dissolution profile for each batch of tablet was deter-
mined using the paddle method with an Erweka DT 600 dissolution 
apparatus. The dissolution medium consisted of 900 ml of freshly 
prepared 0.1 N HCl maintained at 37 ±1°C. A tablet from each 
batch was placed inside a tightly secured basket and the basket 
was placed in the bottom of the beaker. The paddle was rotated at 
100 rpm. At various intervals, 5 ml sample was withdrawn from the 
dissolution medium, filtered (Whatman No. 1) and an aliquot of the 
filtrate was assayed using spectrophotometer (Jenway 6305, UK) at 
277 nm. An equal volume of the withdrawn sample was replaced 
with a fresh medium to maintain sink condition. The amount of drug 
released at each time interval was determined with reference to 





Data were analysed by one-way analysis of variance (ANOVA). 
Differences between means were assessed by a two-tailed 
student’s T-test. P< 0.05 was considered statistically significant.  




The results of the micromeritic properties of metroni-
dazole granules prepared with X. sagittifolium starch as 
binder and disintegrant are presented in Table 2. The 
results show that the granules had a good flow and 
values obtained were within the specified limits for the 
production of good quality tablets. From the results, the 
granules had angle of repose that ranged from 17.43  
0.10 to 25.77  0.10°. These results show that the gra-
nules had low interparticulate friction and hence good 
flow. The results of compressibility index indicate that the 
prepared granules had good flowability and consolidation 
properties. When the CI and HR are adequate, the 
powder flows at minimum bulk density. A high bulk 
density, that is a low porosity, will result in a low deforma-
tion potential, a lack of space for deformation during 
compression will cause less intimate contact between the 
particles within the tablets, resulting in weaker tablets 
(Yüksel et al., 2007; Momoh et al., 2012). Carr’s index in 
the range of 5 to 16% indicates good flow, 18 to 21% 
shows fair flow, while values above 38% show very poor 
flow (Chime et al., 2012) and from the results of Carr’s 
compressibility index shown in Table 2, the granules had 
a fair flow. Hausner’s ratio ≤ 1.25 indicates good flow, 
while values > 1.25 indicates poor flow (Aulton, 2007; 
Yüksel et al., 2007); from the results in Table 2, batches 
M2 and M4 had HQ below 1.25 and hence exhibited 
good flowability. However, batches M1 and M3 had HQ of 
1.28. The results show that the granules had good flow 
rate and could be used to produce standard tablets. 
 
 
Properties of metronidazole tablets 
 
The results of tablets weight uniformity of metronidazole 
tablets are shown in Table 3. From the results, the tablets 
weight ranged from 300.00 ± 1.10 to 302.00 ± 1.03 mg. 
The percentage deviations obtained from the tablet 
weight uniformity test were significantly (p< 0.05) below 
5% stipulated for tablets weight greater than 250 mg (BP, 













(mg ± CV)* 
Drug content  










M1 300.95 ± 1.17 203.00 ± 0.27 3.00 ± 0.08 8.50 ± 1.00 1.29 
M2 300.00 ± 1.10 201.00 ± 0.32 4.73 ± 0.11 7.20 ± 1.25 0.90 
M3 302.00 ± 1.03 205.00 ± 0.71 12.00 ± 0.03 8.55 ± 1.08 0.56 
M4 301.00 ± 0.83 203.00 ± 0.12 14.00 ± 0.10 8.55 ± 1.17 0.77 
 
*Mean for 20 tablets; 
a
Mean for 10 tablets; CV, coefficient of variation; SD, standard deviation; M1, M2, M3 and M4, 




test. Tablet weight uniformity test is a very important 
quality control test because variation in tablets weight will 
lead to variation in drug content and the overall bioavaila-
bility of the drug will be affected.  
The results of assay of active ingredient shown in Table 
3 indicate that the tablets passed the test for the assay of 
active ingredient. The low standard deviation seen in the 
results confirmed that the formulation method adopted 
was reliable. The results also confirmed that there was no 
form of interactions between the X. sagittifolium starch 
and the metronidazole, therefore, X. sagittifolium starch 
may be inert and hence a good excipient for the formu-
lation of metronidazole tablets. 
The tablets disintegration time results presented in 
Table 3 show that the tablets all complied with BP (2009) 
specifications for the disintegration time of normal release 
tablets. Tablets disintegration time ranged from 3.00 ± 
0.08 to 14.00 ± 0.10 min for M1 and M4 tablets formula-
ted with 5 and 20% of X. sagittifolium starch respectively. 
From the results, increase in the concentration of the 
binder significantly increased the disintegration time of 
the metronidazole tablets (p < 0.05). The mechanism of 
disintegration may be by deformation (Ofoefule, 2002). 
Starch grains are generally elastic and at certain 
compression pressure, starch may undergo permanent 
deformation. These permanently deformed grains are rich 
in energy and when exposed to water, the energy is 
released causing disintegration of tablets (Ofoefule, 
2002). 
The results of tablet hardness also shown in Table 3 
show that metronidazole tablets formulated showed a 
good hardness profile and conformed to BP (2009) 
specifications for tablets hardness of between 5 to 8 kgf. 
The tablets hardness ranged from 7.20 ± 1.25 to 8.55 ± 
1.17 kgf. The results of this study showthat the mecha-
nical properties of the tablets would not be compromised 
during packaging, transportation and use. 
The results of tablets friability test presented in Table 2 
show that the tablets friability test ranged from 0.56 to 
1.29%. The tablets therefore, passed the test for friability. 
According to BP (2009) specifications, values of friability 
≤ 1% are acceptable for tablets formulated by wet granu-
lation method but, for tablets prepared by direct compres-
sion, values of friability of up to 2% are acceptable. The 
results show that the tablets could be able to withstand 
shock and vibrations during the packaging, transportation 
and use. 
The results of the drug release profile of metronidazole 
tablets formulated with different concentrations of X. 
sagittifolium starch as binder and disintegrant are shown 
in Figure 1. From the results, all the tablet batches had 
good drug release. The time for the release of 25, 50 and 
90% of metronidazole in all the formulations were 
obtained (T25, T50 and T90). M1 tablets containing 5% of X. 
sagittifolium starch had T25, T50 and T90 at 5, 13 and 23 
min respectively, M2 containing 10% of X. sagittifolium 
starch had T25, T50 and T90 % at 7, 13 and 27 min res-
pectively, M3 containing 15% of X. sagittifolium starch 
had T25, T50 and T90 at 10, 19 and 28 min respectively, 
while the batch M4 tablets containing 20% of X. 
sagittifolium starch had T25, T50 and T90 at 8, 18 min and 
was unable to release 90% of metronidazole at 30 min. 
According to US-FDA guideline, immediate release drug 
products should release 85% (T85 %) of labeled amount of 
drug within 30 min of study (Obitte et al., 2008). There-
fore, the tablets exhibited good drug release properties 
as normal release tablets. 
 
 
Phytochemical constituents of X. sagittifolium starch 
 
The results of the phytochemical constituents of X. 
sagittifolium starch presented in Table 4 showthat the 
starch contained high concentrations of alkaloids, 
glycosides and carbohydrate, and low concentrations of 
steroids. Phytochemicals are non-nutritive plant chemi-
cals that have protective or disease preventive proper-
ties. Plants produce these chemicals substances to 
protect themselves, and they are also believed to protect 





Natural polymers have advantages over the synthetic and 
semi-synthetic polymers which include biocompatibility, 
relatively cheap, easily accessible and physiologically 





































Figure 1. The drug release profile of metronidazole tablets formulated with X. sagittifolium starch as 
binder and disintegrant in 0.1 N HCl. M1, M2, M3 and M4, metronidazole granules prepared with 5, 




Table 4. Phytochemical constituent of X. sagittifolium starch. 
 










to formulate metronidazole tablets giving optimum dis-
integration time and the dissolution profile of this drug. 
The physicochemical properties of the tablets showed 
that the tablets exhibited good quality as normal release 
tablets. However, further studies on the use of X. 
sagittifolium starch as tablet excipients are encouraged in 
order to scale up the production and finally make the 
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